Bausch + Lomb Corporation

NYSE:BLCO

Medical - Instruments & Supplies

Healthcare
$20.95 +0.27%

+$0.04 today

Market cap
$7.49B
Beta
0.57
P/E (TTM)
-24.2
EPS (TTM)
-$0.62
52W Low $11.58High $18.92

Volume 0.51M

Average 0.46M

BLCO Tax Payables

Taxes owed to authorities that have not yet been paid.

Bausch + Lomb CorporationNYSE: BLCO

Tax Payables · Q2 FY2026 · quarter ended Jun 2026

Tax payables remains negative

Q2 FY2026 tax payables was $0, compared with $0 a year earlier.

Context

  • Tax payables amounted to 0.0% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
  • Tax payables increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Year agoJun 2025
$0— since
Tax Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Tax Payables history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Tax Payables vs competitors

How BLCO compares with its peers on the latest reported figures

  • BLCO's Jun 2026 tax payables of $0 is the 3rd highest of the 10 companies compared; the peer median is $0.
  • Tax payables amounts to 0.0% of total assets for BLCO, versus a peer median of 0.0%.
BLCO Competitors Peer median
Tax Payables for BLCO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TFXTeleflex IncorporatedJun 2026$17.79M -20.9%-8.8%0.3%
MMSIMerit Medical Systems, Inc.Sep 2026$14.39M +85.9%-9.6%—
BLCOBausch + Lomb CorporationJun 2026$0 ——0.0%
GKOSGlaukos CorporationJun 2026$0 ——0.0%
PCVXVaxcyte, Inc.Jun 2026$0 ——0.0%
TGTXTG Therapeutics, Inc.Sep 2026$0 ——0.0%
OSCROscar Health, Inc.Jun 2026$0 ——0.0%
ARWRArrowhead Pharmaceuticals, Inc.Sep 2026$0 ——0.0%
PTCTPTC Therapeutics, Inc.Jun 2026$0 -100.0%—0.0%
CRSPCRISPR Therapeutics AGSep 2026$0 -100.0%—0.0%
Peer median (excluding BLCO) $0-60.5%-9.2%0.0%

Competitors are the stored peer set for BLCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents174M380M334M305M383M
Short-term Investments00000
Net Receivables721M726M875M1.03B1.22B
Inventory572M628M1.03B1.04B976M
Other Current Assets3M403M505M421M397M
Total Current Assets1.64B2.14B2.74B2.79B2.98B
Property, Plant & Equipment (Net)1.23B1.42B1.5B1.49B1.76B
Goodwill4.59B4.51B4.58B4.52B4.76B
Intangible Assets2.26B2.06B3.59B3.49B3.28B
Long-term Investments012M19M19M7M
Tax Assets933M927M921M885M934M
Other Non-current Assets180M84M92M275M303M
Total Non-current Assets9.19B9.01B10.7B10.68B11.05B
Total Assets10.82B11.14B13.44B13.47B14.02B
Account Payables239M317M522M389M388M
Short-term Debt28M51M57M40M77M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities356M732M709M459M1.46B
Total Current Liabilities1.1B1.3B1.58B1.74B1.92B
Long-term Debt02.41B4.53B4.74B5.17B
Deferred Tax Liabilities07M14M13M19M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities230M237M310M310M271M
Total Non-current Liabilities322M2.75B4.94B5.19B5.58B
Total Liabilities1.42B4.04B6.52B6.93B7.5B
Common Stock10.36B0000
Retained Earnings06M(254M)(571M)(931M)
Accumulated OCI(1.04B)(1.26B)(1.25B)(1.39B)(1.18B)
Other Stockholders Equity00000
Minority Interest73M68M70M71M71M
Total Equity9.4B7.1B6.92B6.54B6.52B
Total Debt140M2.55B4.68B4.94B5.37B
Net Debt(34M)2.17B4.34B4.63B4.99B

Bausch + Lomb Corporation

NYSE:BLCO

Intrinsic Alpha fair value

Locked

Current Price

$20.95

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.